Cerenome, Inc. (CNSY)
0.6427
-0.03
(-4.06%)
USD |
NASDAQ |
Nov 06, 16:00
0.6601
+0.02
(+2.71%)
After-Hours: 20:00
Cerenome Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.015M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.031M |
| September 30, 2024 | 0.04M |
| June 30, 2024 | 0.05M |
| March 31, 2024 | 3.649M |
| December 31, 2023 | 4.061M |
| September 30, 2023 | 4.466M |
| June 30, 2023 | 4.845M |
| March 31, 2023 | 5.223M |
| December 31, 2022 | 5.535M |
| September 30, 2022 | 5.888M |
| June 30, 2022 | 6.229M |
| March 31, 2022 | 6.561M |
| December 31, 2021 | 6.882M |
| September 30, 2021 | 7.256M |
| June 30, 2021 | 7.148M |
| March 31, 2021 | 6.992M |
| December 31, 2020 | 6.873M |
| September 30, 2020 | 6.765M |
| June 30, 2020 | 6.615M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.81M |
| December 31, 2019 | 11.71M |
| September 30, 2019 | 11.62M |
| June 30, 2019 | 11.56M |
| March 31, 2019 | 15.89M |
| December 31, 2018 | 14.20M |
| September 30, 2018 | 14.01M |
| June 30, 2018 | 13.84M |
| March 31, 2018 | 13.73M |
| December 31, 2017 | 13.62M |
| September 30, 2017 | 13.50M |
| June 30, 2017 | 14.52M |
| March 31, 2017 | 16.09M |
| December 31, 2016 | 17.64M |
| September 30, 2016 | 17.40M |
| June 30, 2016 | 17.16M |
| March 31, 2016 | 16.92M |
| December 31, 2015 | 16.68M |
| September 30, 2015 | 16.42M |
| June 30, 2015 | 16.21M |
| March 31, 2015 | 25.68M |
| December 31, 2014 | 25.40M |
| September 30, 2014 | 25.81M |
| June 30, 2014 | 26.84M |
| March 31, 2014 | 26.57M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Ernexa Therapeutics, Inc. | 0.138M |
| ACADIA Pharmaceuticals, Inc. | 57.32M |
| Anika Therapeutics, Inc. | 24.56M |
| Savara, Inc. | 30.11M |